;%20}%20%3c/style%3e%3clinearGradient%20id='linear-gradient'%20x1='1.11'%20y1='1589.13'%20x2='229.47'%20y2='1589.13'%20gradientTransform='translate(0%201706.13)%20scale(1%20-1)'%20gradientUnits='userSpaceOnUse'%3e%3cstop%20offset='.54'%20stop-color='%23000'%20stop-opacity='0'/%3e%3cstop%20offset='1'%20stop-color='%23000'/%3e%3c/linearGradient%3e%3c/defs%3e%3crect%20class='cls-1'%20x='1.11'%20y='.78'%20width='339.79'%20height='232.43'/%3e%3cpath%20d='M37.18,123.61h-15.78l-4.95,12.17h-2.67l15.61-38.18,15.4,38.18h-2.67l-4.95-12.17h0ZM36.3,121.39l-6.95-17.56-7.05,17.56h14.01,0Z'/%3e%3cpath%20d='M68.8,118h15.56c0,3.39-.73,8.28-3.78,12.17-3.28,4.17-8.28,6.22-13.94,6.22-10.89,0-19.17-8-19.17-19.06s8.56-19.12,19.34-19.12c5.22,0,8.73,1.77,11.61,4,1.56,1.22,2.95,2.55,4.45,4.67l-1.94,1.56c-1.06-1.77-2.55-3.28-3.56-4.11-2.33-1.94-6-3.89-10.61-3.89-9.5,0-16.72,7.56-16.72,17s7,16.72,16.56,16.72c6.34,0,10.89-3.23,12.9-6.28,1.44-2.22,2.33-5.28,2.45-7.67h-13.11v-2.22l-.02.02Z'/%3e%3cpath%20d='M110.14,100.94h-15.33v13.45h15v2.22h-15v16.95h15.33v2.22h-17.78v-37.07h17.78v2.22Z'/%3e%3cpath%20d='M131.09,98.71h8.11c6.44,0,10.23,3.72,10.23,9.28,0,4-1.89,6.61-4.34,8.11,4.83.78,7.67,4.5,7.67,9.28,0,6.5-4.78,10.4-11.51,10.4h-10.17v-37.07h0ZM133.53,115.5h5.89c1.89,0,3.44-.22,5.05-1.56,1.5-1.22,2.45-3.11,2.45-5.66,0-2.95-1.28-4.78-2.5-5.78-1.84-1.44-4.22-1.56-6.17-1.56h-4.72v14.56ZM133.53,133.56h6.23c2.5,0,5.56,0,8.06-2.22,2-1.77,2.39-3.94,2.39-5.66,0-3.33-1.17-5.61-3.94-6.89-1-.45-2.83-1.06-6.95-1.06h-5.78v15.84h0Z'/%3e%3cpath%20d='M179.93,123.61h-15.78l-4.95,12.17h-2.67l15.61-38.18,15.4,38.18h-2.67l-4.95-12.17h0ZM179.04,121.39l-6.95-17.56-7.05,17.56h14.01,0Z'/%3e%3cpath%20d='M221.88,106.27c-3.16-3.72-7.72-5.83-12.5-5.83-9.5,0-16.62,7.61-16.62,17,0,11,9.17,16.72,16.67,16.72,3.72,0,8.67-1.5,12.45-5.61v3.23c-3.78,3.33-8.33,4.61-12.34,4.61-11.11,0-19.34-8.72-19.34-19.06s8.56-19.12,19.22-19.12c7.05,0,11.34,3.78,12.45,4.83v3.23h0Z'/%3e%3cpath%20d='M235.1,116.44l17.95-17.73h-3.23l-17.5,17.45v-.56c-.36.69-.93,1.27-1.71,1.6.05.42.02.84-.06,1.26.72.03,1.33.22,1.82.54l.94-.89,17.45,17.67h3.33l-19.01-19.34h0Z'/%3e%3cpath%20d='M302.5,106.27c-3.16-3.72-7.72-5.83-12.5-5.83-9.5,0-16.62,7.61-16.62,17,0,11,9.17,16.72,16.67,16.72,3.72,0,8.67-1.5,12.45-5.61v3.23c-3.78,3.33-8.33,4.61-12.34,4.61-11.11,0-19.34-8.72-19.34-19.06s8.56-19.12,19.22-19.12c7.05,0,11.34,3.78,12.45,4.83v3.23h0Z'/%3e%3cpath%20d='M330.67,124.5c0,6.72-5.17,11.89-11.89,11.89s-11.89-5.17-11.89-11.89,5.17-11.89,11.89-11.89,11.89,5.17,11.89,11.89ZM328.34,124.5c0-5.5-4.11-9.78-9.55-9.78s-9.55,4.28-9.55,9.78,4.11,9.78,9.55,9.78,9.55-4.28,9.55-9.78Z'/%3e%3cpath%20d='M338.84,132.05c1.17,0,2.05.89,2.05,2.05s-.89,2.05-2.05,2.05-2.05-.89-2.05-2.05.89-2.05,2.05-2.05Z'/%3e%3cpath%20class='cls-2'%20d='M117.32,233.21C53.24,233.21,1.11,181.07,1.11,117S53.24.78,117.32.78c51.99,0,98.03,34.94,111.97,84.97l-2.23.62C213.4,37.34,168.28,3.1,117.32,3.1,54.52,3.1,3.42,54.19,3.42,117s51.1,113.9,113.9,113.9c51.27,0,96.47-34.52,109.92-83.93l2.23.61c-13.71,50.42-59.83,85.65-112.15,85.65h0Z'/%3e%3cpath%20d='M230.86,136.5l-2.28-.39c2.11-12.49,2.14-25.18.08-37.71l2.28-.37c2.09,12.79,2.06,25.73-.08,38.47Z'/%3e%3c/svg%3e)
Cell Therapies
Stem cell therapy based on world-leading research
To watch this video, please accept marketing cookies.
What is Cell Therapies?
Delivered with c-GMP certified cells from our lab Vivosel and strict clinical oversight at leading hospitals. Complete our eligibility form to verify your qualification and request a consultation for participation in Age Back Co's ongoing stem cell trials, approved by national ethics committees.
Program Focus Areas
Orthopedic Programs
Regulated MSC and exosome applications for degenerative joint conditions.
Neurological Programs
Clinical pathways for cognitive and post-viral indications.
Metabolic & Immune Programs
Structured evaluation for autoimmune and early metabolic disease.
IV & Local Protocols
Hospital-based administration under physician oversight.
Access Pathway
Screening & Specialist Review
Submit your information for preliminary review and discussion of program eligibility.
Program Proposal
Receive a structured outline of the proposed treatment pathway and next steps.
Program Confirmation
Confirm participation to proceed to formal physician consultation.
Medical Consultation
Physician evaluation and preparation of application for regulatory review.
Regulatory Review
Upon approval, treatment is scheduled at a licensed hospital.
Who May Be Eligible
- Individuals with documented degenerative joint or connective tissue conditions seeking regulated, hospital-based treatment options.
- Patients with diagnosed neurological, post-viral, metabolic, or autoimmune conditions under physician supervision.
- Individuals who have undergone prior conservative or surgical treatment and are exploring structured cellular therapy programs.
- Patients prepared to participate in formal medical evaluation and regulatory review processes.
Frequently Asked Questions
Access Cell Therapies
Begin with a personalized consultation to discuss your goals and create a tailored treatment plan. Our medical team will guide you through every step of your journey.
Get AccessLearn More About Our Programs & Infrastructure
For additional information about our clinical programs and manufacturing platform: